Welcome to ComplianceWeek.com. This site uses cookies. Read our policy.

Our two-day financial crimes event considers brand-new regulatory and legal mandates; examines lessons learned from enforcement actions; and airs industry perspectives on the latest developments in the financial crime space, including money laundering, bribery, sanctions violations, market manipulation, and more.

Learn from the latest headlines and protect your company today

Companies not reporting ESG initiatives are in the minority
KPMG UK chair resigns over controversial pandemic remarks
Q&A: Global Widget CCO says CBD industry at regulatory ‘tipping point’
Survey: Pandemic pervades executives’ top 10 risks for 2021

Individual Corporate

All Teva Pharmaceuticals articles

Article
Teva to pay $54M in FCA whistleblower settlement

2020-01-07T20:01:00Z

Teva Pharmaceuticals has reached a $54 million settlement in a lawsuit filed by two whistleblowers over allegations the drug company bribed physicians through numerous “sham” speaker programs in exchange for prescribing Teva drugs.

Learn from the latest headlines and protect your company today

All Teva Pharmaceuticals articles

Teva to pay $54M in FCA whistleblower settlement